March 17, 2020 / 3:59 PM / in 12 days

BRIEF-Adial Pharmaceuticals Announces Modifications To Phase 3 Pivotal Trial Of Ad04 To Protect Subjects From Covid-19

March 17 (Reuters) - Adial Pharmaceuticals Inc:

* ADIAL PHARMACEUTICALS INC. - ADIAL PHARMACEUTICALS ANNOUNCES MODIFICATIONS TO PHASE 3 PIVOTAL TRIAL OF AD04 TO PROTECT SUBJECTS FROM COVID-19

* ADIAL PHARMACEUTICALS - IN PROCESS OF MODIFYING PROTOCOL TO REDUCE NO. OF IN-PERSON VISITS TO CLINICAL SITES

* ADIAL PHARMACEUTICALS INC - DURATION OF IN-PERSON VISITS IS BEING REDUCED THROUGH REMOVAL OF NON-ESSENTIAL ASSESSMENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below